Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
ConditionArrhythmia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorWonju Severance Christian Hospital
About this trial
HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.
Eligibility criteria
Qualifiers
Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
Patients who can use a smartphone
Disqualifiers
Patients who have cardiac implantable electronic devices(CIEDs)
Patients who can't use handheld ECG
Trial design
Treatments tested in this trial
- Continous ECG Patch
- Intermittent handheld ECG
Treatment groups
588 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov